This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A brief guide to blue chip alternatives beyond BTC and ETH, highlighting characteristics that define blue chip status and potential rewards.
20,411 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Dell Technologies is pursuing aggressive AI data center growth, backed by a sizable backlog, while HP Inc. grapples w...
Beyond Meat has faced a sharp drop in price, flirting with Nasdaq's $1 threshold. This piece breaks down what a rever...
Nebius has drawn attention with bold AI capacity announcements and aggressive revenue targets. This guide breaks down...
XRP has surged past BNB to claim the fourth-largest spot by market capitalization as Ripple unveils a Brazil expansio...
Today’s session showed a rally fade for Plug Power and a broader pullback in hydrogen names. This article breaks down...
The YieldMax MSFT Option Income Strategy ETF (MSFO) continues to lure income-seeking investors with weekly payouts, b...
South Korea faces a major shift as lawmakers push to abolish the crypto capital gains tax amid a dramatic capital fli...
If you’re targeting 2030 for your retirement, timing your Social Security claim could be the biggest financial move y...
Rocket Lab is tightening revenue visibility with a growing backlog and stronger margins entering 2026. Analysts eye h...
Rivian and NIO shares fell about 7% amid renewed skepticism about rapid EV growth. Investors are demanding clear prof...
Three weeks into iran, the conflict has pushed energy prices higher and tightened budgets for families. Here’s what h...